Smart Contact Lenses with Biosensors: Measuring Health Through Tear Fluid
Smart contact lenses with built-in biosensors are being developed to measure chemical and physical changes on the surface of the eye. Instead of collecting a blood sample or placing a sensor under the skin, these lenses remain in direct contact with tear fluid and can potentially record health information while the wearer continues with normal daily activities. Researchers have tested lenses for monitoring glucose, uric acid, inflammation-related proteins, oxygen levels and other indicators linked to metabolic or ocular health. Progress reported by 2026 shows that continuous tear analysis is technically possible, including in human participants. However, most tear-sensing lenses remain investigational devices rather than routine medical products. Their future depends not only on sensor sensitivity but also on reliable calibration, comfortable materials, clinical validation and evidence that tear measurements can support safe medical decisions.
Why Tear Fluid Can Provide Useful Health Information
Tear fluid is more than the water produced when the eyes are irritated or a person cries. The thin tear film covering the eye contains water, salts, proteins, lipids, enzymes, hormones and small metabolic compounds. Some of these substances originate locally in the eye, while others are influenced by processes elsewhere in the body. Glucose, lactate and uric acid are among the metabolic indicators that researchers have measured in tears. Proteins associated with inflammation may also provide information about dry eye disease, corneal damage or other ocular conditions. This chemical variety makes tears an attractive source of health data, particularly because they can be reached without puncturing the skin.
The relationship between a substance in tears and the same substance in blood is rarely simple. Tear concentrations may be much lower, and changes can appear later than changes in the bloodstream. Results may also be affected by tear production, blinking, evaporation, eye drops, contact lens movement, recent food intake and individual physiology. Reflex tears produced by wind, irritation or lens insertion can dilute the sample and produce a reading that differs from the composition of normal basal tears. A clinically useful lens must therefore determine whether it is measuring a genuine health change or a temporary alteration caused by conditions around the eye.
Continuous monitoring may address some weaknesses of occasional tear sampling. A contact lens can remain in contact with basal tears and collect repeated readings rather than relying on one sample taken with a strip or capillary tube. Changes can then be assessed as a pattern over time. A single value may be difficult to interpret, whereas a sequence of readings can show whether a marker is rising, falling or remaining stable. This approach could be particularly useful for conditions that fluctuate during the day. Continuous access alone is not enough, however. The lens must remain properly positioned, allow oxygen to reach the cornea and avoid stimulating additional tearing that would distort the measurements.
What a Biosensing Contact Lens Actually Measures
A smart lens normally contains a sensing area that reacts to a selected substance or physical condition. An electrochemical glucose sensor, for example, can use an enzyme that reacts with glucose and produces a small electrical change. Other designs rely on optical effects: the presence of a substance may alter colour, fluorescence or reflected light. The reading may be processed by miniature electronic components and transferred wirelessly to a nearby reader or mobile device. Some experimental lenses receive power through near-field communication, removing the need to place a conventional battery on the eye. Simpler optical designs may be read with a camera or compact optical reader.
Glucose has received considerable attention because frequent monitoring is central to diabetes management. A 2024 study used a soft, wireless contact lens to record tear glucose at intervals of less than one minute. The researchers tested the system in people with and without diabetes as well as in animal models. They reported that the relationship between tear and blood glucose improved when the analysis considered an individual delay between changes in the two fluids. This personalised lag time is important because a tear reading may not represent the blood glucose level at the same moment. The study strengthened the evidence that tears can reflect glucose trends, but it did not establish that a lens can replace an authorised blood or interstitial-fluid glucose monitor.
Uric acid became another important research target in 2026. Elevated uric acid in the blood is associated with hyperuricaemia and gout, although diagnosis and treatment decisions require appropriate clinical assessment. Researchers reported a wireless contact lens that continuously measured uric acid in tears and tested the relationship with serum levels in human participants, including people with gout or hyperuricaemia. The recorded data were also used to build personalised computer models of how uric acid changed after meals and physical activity. These findings indicate that tear monitoring may eventually complement laboratory testing, but larger studies are needed to determine how well the method performs across different ages, health conditions, medicines and daily routines.
Health Applications Being Investigated in 2026
Metabolic monitoring is one of the most widely discussed uses of tear biosensors. Glucose sensors could potentially record trends after meals, exercise, sleep or medication, while uric acid sensors may help researchers understand how diet and activity affect individual metabolic responses. Other experimental systems have targeted lactate, cholesterol, electrolytes and cortisol. Each marker presents different difficulties. Some occur in tears at very low concentrations, while others may respond strongly to stress, physical exertion or local eye conditions. A lens designed for medical use would need to distinguish meaningful changes from normal biological variation and explain results in a form that patients and clinicians can interpret correctly.
Smart lenses may also support the assessment of eye health. Researchers have created contact lens sensors for matrix metalloproteinase-9, commonly known as MMP-9, a protein associated with inflammation on the ocular surface. Other prototypes have measured tear pH, temperature, moisture and dissolved oxygen. Such measurements could contribute to the management of dry eye disease, corneal inflammation or problems related to reduced oxygen supply. Continuous observation may reveal changes that are missed during a brief appointment. It could also help clinicians evaluate how the eye responds to contact lens wear, environmental conditions or treatment. These applications still require clear clinical thresholds so that a changing sensor signal can be linked to a defined medical action.
Another research area involves physical measurements rather than tear chemistry. Contact lens sensors can detect small changes associated with pressure patterns in the eye. The SENSIMED Triggerfish is an example of a prescription sensor that has received US regulatory authorisation. It records changes in ocular dimensions for up to 24 hours to help identify when intraocular pressure may be increasing. It does not directly measure intraocular pressure and does not diagnose glaucoma by itself. Its role is to help clinicians select an appropriate time for conventional pressure measurement. This distinction illustrates an important principle: a wearable sensor may provide valuable supporting information without replacing the established examination used to diagnose or manage a condition.
What Recent Research Has Demonstrated
A 2025 study described an optical contact lens with a patterned nanostructure designed to respond to different glucose concentrations. The researchers produced the curved sensing surface using a relatively simple manufacturing method and tested it with glucose dissolved in a laboratory solution that simulated some aspects of tear fluid. The lens responded across a range that included low glucose concentrations and showed good cell compatibility during an in vitro test. These results are useful for improving optical sensor design, but they should not be interpreted as clinical proof. Laboratory solutions are more controlled than real tears, which contain proteins, salts, lipids and other substances that may affect a sensor’s response.
Comfort and oxygen delivery are equally important. A sensor may produce accurate readings on a laboratory bench but still be unsuitable for the eye if it is rigid, thick or poorly ventilated. In 2025, researchers reported an ultrathin lens with a flexible cut pattern that helped the electronics conform to the curved surface. The prototype measured dissolved oxygen, humidity and temperature and transmitted the readings wirelessly. Animal testing in beagle eyes showed that the system could monitor changes under controlled conditions. The work addressed a genuine safety concern because the cornea receives much of its oxygen directly from the air. Any electronics, protective coating or sensing layer added to a lens must preserve sufficient oxygen transmission.
Research published in 2026 also examined a battery-free, all-polymer lens for glaucoma-related monitoring and treatment. The device used microfluidic channels to respond to changes linked to intraocular pressure and included a mechanism for releasing medication when selected pressure conditions were reached. Testing was conducted in preclinical models rather than routine patient care. The study is notable because it combined sensing and treatment without conventional rigid electronic components. Even so, an automated treatment lens would face demanding safety requirements. It would need to measure pressure reliably, release an exact dose, prevent accidental activation and continue working despite blinking, movement and changes in the tear environment.
Barriers Between Research Prototypes and Everyday Medical Use
Measurement accuracy remains one of the central difficulties. Tear biomarkers are often present in small quantities, so a sensor must respond to the intended substance without being confused by other compounds. Proteins may attach to the sensing surface over time and alter its performance. Temperature and pH can also influence chemical reactions. In addition, two people with the same blood value may not have identical tear values. A practical system may therefore require an initial calibration period and a personalised baseline. Researchers must also determine how frequently a lens needs recalibration and whether its accuracy changes after several hours of wear.
Engineering requirements create another set of constraints. The lens must be soft, transparent and stable while allowing enough oxygen to reach the cornea. Electronic components need protection from moisture, yet the sensing area must remain exposed to tears. Wireless power and communication must operate without producing harmful heat. The lens should also fit different eye shapes without shifting the sensor away from its intended position. A reusable device would require safe cleaning and storage, while a disposable design would need to be affordable enough for regular replacement. Every additional function increases the difficulty of keeping the lens thin and comfortable.
Clinical evidence must go beyond demonstrating that a sensor produces a signal. Researchers need to compare readings with recognised laboratory or clinical methods in large and varied groups of participants. Studies should include people with the relevant condition as well as healthy controls and should examine the effects of age, medicine use, tear disorders and environmental conditions. Clinicians also need evidence that acting on the data improves patient care. Current authorised continuous glucose monitors measure glucose in interstitial fluid under the skin, not in tears. Experimental tear-glucose lenses should therefore not be used as substitutes for approved monitoring equipment or for tests recommended by a healthcare professional.
What Patients and Clinicians Can Realistically Expect Next
The first broadly useful tear-sensing lenses are likely to focus on one clearly defined task rather than trying to measure every possible health indicator. A lens for monitoring an ocular marker may reach clinical practice sooner than a lens intended to estimate several systemic conditions at once because local eye measurements may require fewer assumptions about the relationship between tears and blood. Short-term use under professional supervision may also be easier to validate than continuous unsupervised wear. Devices could initially support specialist assessments, treatment studies or home monitoring programmes for selected patients before becoming suitable for wider use.
Data interpretation will be as important as the lens itself. A mobile application may display trends, but a changing graph does not automatically indicate illness. Future systems will need clear rules for identifying unreliable readings, sensor movement or unusual tear production. Personalised models may help account for the delay between tear and blood changes, as demonstrated in glucose and uric acid research. At the same time, health data collected near-continuously raise questions about privacy, storage and access. Manufacturers and healthcare providers will need to explain what information is recorded, where it is kept and whether it is used for purposes beyond the person’s medical care.
By 2026, smart contact lenses have moved beyond simple laboratory demonstrations, with several studies reporting wireless monitoring, human testing or preclinical treatment functions. The evidence supports continued development, but it does not justify treating tear analysis as an established replacement for blood tests, clinical eye examinations or authorised medical sensors. Anyone wearing a contact lens must still follow professional fitting, hygiene and replacement guidance. Water exposure, poor cleaning and extended wear can increase the risk of irritation or infection, regardless of whether the lens contains electronics. The most credible future for biosensing lenses is as carefully validated medical equipment that adds continuous information to existing care rather than removing the need for clinicians and established diagnostic methods.